Pancragen (20MG)

What Is Pancragen?

Pancragen is a synthetic tetrapeptide bioregulator with the amino acid sequence Lys-Glu-Asp-Trp (KEDW). It belongs to the Khavinson peptide series a family of short-chain peptides developed through research on tissue-specific bioregulators. Originally identified from peptide fractions isolated from bovine pancreatic tissue, Pancragen represents a targeted approach to investigating pancreatic cell biology and function.

As a tetrapeptide a peptide composed of exactly four amino acids Pancragen has attracted research interest for its potential to interact with nuclear structures such as DNA and histones, supporting gene transcription and cellular differentiation in pancreatic cells. Researchers classify Pancragen as a peptide bioregulator, meaning it may influence cellular processes through epigenetic and transcriptional mechanisms rather than through classical receptor-mediated signaling. For those looking to buy Pancragen 20mg in Switzerland, Core Peptides offers high-quality research-grade material for laboratory applications.

Pancragen Research Overview

Pancragen represents a well-documented peptide bioregulator within the Khavinson research program. The peptide’s design a simple tetrapeptide sequence of lysine, glutamic acid, aspartic acid, and tryptophan belies its complex biological activity. Researchers have investigated Pancragen primarily for its tissue-specific effects on pancreatic cells, with implications for understanding pancreatic function, glucose metabolism, and age-associated metabolic processes.

Research interest in Pancragen centers on its ability to stimulate the expression of differentiation factors in both acinar and islet pancreatic cells. Studies have demonstrated that Pancragen influences the expression of critical transcription factors including PDX1, PAX6, PAX4, FOXA2, and NKX2.2 genes essential for pancreatic cell development and function. Consequently, Pancragen has generated significant interest as a research tool for investigating pancreatic biology, diabetes mechanisms, and age-related metabolic decline.

When researchers choose to buy Pancragen 20mg in Switzerland for laboratory studies, they gain access to a compound that may help elucidate mechanisms of pancreatic cell differentiation, glucose regulation, and metabolic homeostasis at the molecular level.

How Does Pancragen Work?

The proposed mechanism of Pancragen involves direct nuclear interactions and epigenetic regulation of pancreatic gene expression. Researchers believe Pancragen can penetrate cellular membranes to reach the nucleus, where it interacts with DNA and histones to modulate transcriptional activity.

Transcriptional Regulation of Pancreatic Genes

Studies have shown that Pancragen upregulates critical development genes controlling pancreatic cell maturation and function. Specifically, research has documented increased expression of PDX1 (1.6-fold), NGN3 (2.7-fold), and PAX6 (1.8-fold) following Pancragen treatment. These transcription factors play essential roles in pancreatic development, beta-cell differentiation, and maintenance of pancreatic islet function.

Furthermore, Pancragen stimulates the expression of differentiation factors in both acinar cells (PDX1, PTF1A) and islet cells (PDX1, PAX6, PAX4, FOXA2, NKX2.2). This tissue-specific stimulation suggests that Pancragen may influence both the exocrine and endocrine functions of the pancreas through coordinated transcriptional regulation.

Epigenetic Mechanisms

Investigations suggest that Pancragen may regulate intracellular signaling and epigenetic pathways governing cellular aging and functional maintenance. By interacting with nuclear structures, Pancragen may influence gene expression patterns that support pancreatic cell health and function, particularly in the context of age-related decline.

Researchers who buy Pancragen 20mg in Switzerland for research purposes can investigate these mechanisms across diverse experimental models.

Why Is Pancragen Studied?

Researchers study Pancragen primarily for its potential relevance to pancreatic biology, glucose metabolism, and age-related metabolic dysfunction. The peptide’s ability to influence pancreatic cell differentiation and gene expression makes it a valuable tool for understanding the molecular basis of pancreatic function and metabolic regulation.

The peptide’s tissue-specific effects on pancreatic cells have made it a focus of diabetes and metabolic research. Preclinical studies have explored Pancragen’s effects on glucose metabolism, insulin sensitivity, and pancreatic islet function in various experimental models, including streptozotocin-induced diabetes in rats and age-related glucose intolerance in non-human primates.

Moreover, researchers study Pancragen in the context of age-related metabolic decline. As pancreatic function naturally diminishes with age, understanding mechanisms that support pancreatic health has become increasingly important. Pancragen represents one well-documented avenue of research inquiry in this area.

Researchers who buy Pancragen 20mg in Switzerland from Core Peptides can incorporate this peptide into their studies on pancreatic cell differentiation, glucose metabolism, insulin sensitivity, and age-related metabolic research.

Pancragen Research Areas

Research Area	Description
Pancreatic Cell Differentiation	Investigating Pancragen’s potential to stimulate differentiation of acinar and islet pancreatic cells
Glucose Metabolism	Studying Pancragen’s effects on blood glucose levels and glucose tolerance
Insulin Sensitivity	Examining Pancragen’s influence on insulin production, secretion, and sensitivity
Transcriptional Regulation	Exploring Pancragen’s effects on pancreatic gene expression (PDX1, PAX6, NGN3, etc.)
Epigenetic Research	Investigating Pancragen’s interaction with DNA, histones, and epigenetic mechanisms
Beta-Cell Health	Preclinical research into Pancragen’s potential to support pancreatic beta-cell function
Age-Related Metabolic Research	Studying Pancragen’s effects on age-related decline in pancreatic function
Diabetes Research	Exploring Pancragen’s potential relevance to glucose regulation and insulin resistance

Scientific Research on Pancragen

Researchers have conducted scientific studies on Pancragen in both in vitro and in vivo settings, deriving evidence from cell cultures, rodent models, and non-human primate studies. The peptide originates from the Khavinson research program, which has investigated tissue-specific peptide bioregulators for several decades.

In Vitro Evidence

In vitro studies have demonstrated that Pancragen stimulates the expression of differentiation factors in pancreatic cell cultures. Research has shown that Pancragen upregulates PDX1 (1.6-fold), NGN3 (2.7-fold), and PAX6 (1.8-fold), genes critical for pancreatic cell maturation and function. Additionally, Pancragen stimulates differentiation factors in both acinar cells (PDX1, PTF1A) and islet cells (PDX1, PAX6, PAX4, FOXA2, NKX2.2). These findings suggest that Pancragen may influence both the exocrine and endocrine functions of the pancreas.

Preclinical Animal Studies

In rodent models, researchers have investigated Pancragen’s effects on glucose metabolism. A study in Wistar rats with experimental streptozotocin-induced diabetes mellitus found that oral Pancragen produced a pronounced hypoglycemic effect during treatment. Intramuscular administration of Pancragen normalized the adhesion of mesenteric capillary endothelium.

Furthermore, research has explored Pancragen’s tissue-specific effects in organotypic tissue cultures. Studies using explants from the pancreas of young and aged rats demonstrated that Pancragen showed a stimulating effect in appropriate tissue cultures.

Non-Human Primate Studies

Two primate studies provide some of the strongest preclinical evidence for Pancragen. A 2015 study administered Pancragen to aged female rhesus monkeys (20–25 years old) and demonstrated reductions in fasting blood glucose levels and normalization of insulin and C-peptide values, suggesting restoration of age-related glucose intolerance.

Researchers concluded that Pancragen is effective and safe for correcting age-related imbalances in endocrine pancreatic function and may have potential for addressing age-related dysfunction of the pancreatic islet apparatus.

Human Research

Pancragen has limited human clinical evidence. Of 8 total research sources identified, only one human study with no randomized controlled trials has been documented. Available evidence primarily derives from in vitro and animal research. Findings should be interpreted as experimental rather than established. Scientists who buy Pancragen 20mg in Switzerland should remain aware of these evidence considerations.

Pancragen Compared With Related Peptides

Peptide	Relationship to Pancragen	Key Differences
Bronchogen	Same Khavinson peptide series, different tissue target	Bronchogen (Ala-Glu-Asp-Leu) targets bronchial epithelial cells; Pancragen targets pancreatic cells
Vesugen	Same Khavinson peptide series, different tissue target	Vesugen (Lys-Glu-Asp) targets fibroblasts; Pancragen (Lys-Glu-Asp-Trp) targets pancreatic cells
Livagen	Same Khavinson peptide series	Livagen targets liver tissue; Pancragen targets pancreatic tissue
Pinealon	Same Khavinson peptide series	Pinealon targets pineal gland; Pancragen targets pancreas
Testagen	Same Khavinson peptide series	Testagen targets testicular tissue; Pancragen targets pancreatic tissue

Research Applications

Researchers utilize Pancragen in a variety of laboratory research applications, primarily in the fields of pancreatic biology, metabolism, and endocrinology. Key research applications include:

• Pancreatic Cell Differentiation Studies: Investigating Pancragen’s potential to stimulate differentiation of acinar and islet pancreatic cells
• Glucose Metabolism Research: Studying Pancragen’s effects on blood glucose levels, glucose tolerance, and metabolic regulation
• Insulin Sensitivity Studies: Examining Pancragen’s influence on insulin production, secretion, and sensitivity
• Transcriptional Regulation Research: Exploring Pancragen’s effects on pancreatic gene expression including PDX1, PAX6, and NGN3
• Epigenetic Research: Investigating Pancragen’s interaction with DNA, histones, and epigenetic mechanisms
• Beta-Cell Research: Preclinical research into Pancragen’s potential to support pancreatic beta-cell function
• Age-Related Metabolic Research: Studying Pancragen’s effects on age-related decline in pancreatic function
• Diabetes Research: Exploring Pancragen’s potential relevance to glucose regulation and insulin resistance

Researchers who buy Pancragen 20mg in Switzerland can incorporate this peptide into their experimental protocols across these diverse research areas.

Pancragen Product Specifications

Specification	Detail
Product Name	Pancragen
Amount	20mg
Form	Lyophilized powder
Sequence (Three-Letter)	Lys-Glu-Asp-Trp (KEDW)
Sequence (One-Letter)	KEDW
Molecular Formula	C26H36N6O9
Molecular Weight	Approximately 576.6 g/mol
CAS Number	Not verified / not provided
Synonyms	Lys-Glu-Asp-Trp, KEDW, Pancragen tetrapeptide
Research Category	Cellular Research & Signaling
Purity	Not provided
Storage	Refer to product documentation

How to Evaluate Pancragen Quality

When sourcing Pancragen for research purposes, researchers should consider several quality indicators. A reliable Pancragen peptide supplier should provide:

• Identity Confirmation: Analytical verification that the peptide matches the expected sequence (Lys-Glu-Asp-Trp, KEDW) and molecular weight (approximately 576.6 g/mol)
• Purity Analysis: Documentation of purity through methods such as HPLC (High-Performance Liquid Chromatography)
• Batch Information: Clear lot numbers and batch traceability
• Certificate of Analysis (CoA): Documentation of analytical testing results
• Proper Labeling: Accurate product identification and storage instructions

Researchers looking to buy Pancragen 20mg in Switzerland should seek suppliers who provide comprehensive documentation and quality assurance. Core Peptides remains committed to supporting research with properly documented products.

Understanding the Certificate of Analysis

A Certificate of Analysis (CoA) provides analytical data for a specific batch of a research peptide. For Pancragen research, a CoA typically includes:

• Identity Confirmation: Mass spectrometry or other analytical methods confirming the peptide’s identity
• Purity Assessment: HPLC chromatograms showing the purity of the peptide
• Batch/Lot Information: Unique identifiers for traceability
• Analytical Methods: Description of the testing methods used

Importantly, researchers should understand that a CoA demonstrates the chemical identity and purity of a peptide but does not establish safety, efficacy, therapeutic effectiveness, or suitability for human use. The CoA serves as a quality control document for research purposes only.

Storage and Stability

Proper storage of research peptides is essential for maintaining their integrity and stability. For Pancragen 20mg, researchers should refer to the product documentation provided with their order for specific storage recommendations.

General best practices for peptide storage include keeping lyophilized peptides in a cool, dry environment, protected from light and moisture. For specific temperature requirements and reconstitution protocols, consult the applicable product documentation or contact Core Peptides for the applicable storage specifications.

Research Considerations

Researchers incorporating Pancragen into their studies should be aware of several important considerations:

• Evidence Limitations: Pancragen has limited human clinical evidence. Of 8 total research sources identified, only one human study with no randomized controlled trials has been documented. Most research has occurred in preclinical models.
• Experimental Status: Researchers consider Pancragen an experimental compound. Therefore, findings should be interpreted within the context of early-stage research.
• Model Differences: Results from cell cultures, rodent models, and non-human primates may not translate directly to human outcomes.
• Regulatory Status: Pancragen is not FDA-approved and is intended for laboratory research use only.
• Quality Considerations: Researchers should verify the quality and identity of their Pancragen through appropriate analytical methods.
• Tissue Specificity: Pancragen demonstrates tissue-specific effects on pancreatic cells. Researchers should consider this specificity when designing experiments.
• Mechanistic Context: Pancragen’s proposed mechanisms involve epigenetic and transcriptional regulation. Researchers should consider appropriate experimental approaches to investigate these pathways.

Researchers who buy Pancragen 20mg in Switzerland should ensure their studies include appropriate controls and interpret findings with scientific rigor.

Frequently Asked Questions About Pancragen

What is Pancragen?

Pancragen is a synthetic tetrapeptide bioregulator with the amino acid sequence Lys-Glu-Asp-Trp (KEDW), developed in the Khavinson peptide research program.

What is Pancragen researched for?

Researchers primarily investigate Pancragen for its potential effects on pancreatic cell differentiation, glucose metabolism, insulin sensitivity, and age-related metabolic function.

What is the amino acid sequence of Pancragen?

The amino acid sequence of Pancragen is Lys-Glu-Asp-Trp (KEDW).

What is the molecular weight of Pancragen?

The molecular weight of Pancragen is approximately 576.6 g/mol.

Is Pancragen a Khavinson peptide?

Yes, Pancragen belongs to the Khavinson peptide series—a family of short-chain peptide bioregulators developed through research on tissue-specific regulators.

What pancreatic genes does Pancragen influence?

Research has shown that Pancragen upregulates PDX1, NGN3, PAX6, PAX4, FOXA2, NKX2.2, and PTF1A—genes critical for pancreatic cell development and function.

Does Pancragen have human clinical evidence?

Pancragen has limited human clinical evidence. Of 8 total research sources identified, only one human study with no randomized controlled trials has been documented.

Is Pancragen FDA-approved?

Pancragen is not FDA-approved. It is intended for laboratory research use only and is not approved for human consumption or therapeutic use.

Can I buy Pancragen in Switzerland?

Yes, researchers can buy Pancragen 20mg in Switzerland from Core Peptides for laboratory research purposes.

What is the primary research category for Pancragen?

Pancragen belongs to the Cellular Research & Signaling category, with secondary relevance to Anti-Aging & Longevity research.

What related peptides are studied alongside Pancragen?

Related peptides from the Khavinson series include Bronchogen, Vesugen, Livagen, Pinealon, and Testagen.

What is the mechanism of action for Pancragen?

Pancragen is thought to penetrate cellular membranes, reach the nucleus, and interact with DNA and histones to modulate transcriptional activity of pancreatic genes.

What animal models have been used in Pancragen research?

Researchers have studied Pancragen in rodent models (streptozotocin-induced diabetic rats) and non-human primates (aged rhesus monkeys with glucose intolerance).

How should Pancragen be stored?

Refer to the product documentation for specific storage recommendations. Peptides are generally stored lyophilized in cool, dry conditions.

Is Pancragen tissue-specific?

Yes, Pancragen demonstrates tissue-specific effects on pancreatic cells, stimulating differentiation factors in both acinar and islet pancreatic cells.

Related Research Peptides

Researchers interested in Pancragen may also find the following related peptides relevant to their work:

• Bronchogen – A Khavinson tetrapeptide targeting bronchial epithelial cells
• Vesugen – A Khavinson tripeptide targeting fibroblasts
• Livagen – A Khavinson peptide targeting liver tissue
• Pinealon – A Khavinson peptide targeting the pineal gland
• Testagen – A Khavinson peptide targeting testicular tissue

For a comprehensive selection of research peptides in Switzerland, explore the Core Peptides catalog.

Explore Cellular Research & Signaling Peptides

Pancragen is part of our Cellular Research & Signaling category, which features a range of research peptides investigated for their effects on cellular function, gene expression, and signaling pathways. Browse our selection to find the right peptides for your laboratory research.

Explore Related Research Categories

Researchers may also find the following related categories relevant to Pancragen research:

• Anti-Aging & Longevity – Peptides investigated for age-related research applications
• Growth Hormone Peptides – Peptides studied for metabolic and growth-related research
• Healing & Regeneration Peptides – Peptides investigated for tissue regeneration and repair

Further Research

Researchers interested in learning more about Pancragen and related peptides should consult the primary scientific literature. Key areas of investigation include pancreatic cell differentiation, glucose metabolism, transcriptional regulation, and epigenetic mechanisms. The PubMed database is an excellent resource for accessing peer-reviewed research articles on these topics.

Research Disclaimer

Core Peptides supplies Pancragen as a research peptide for laboratory research purposes only. It is not approved for human consumption, therapeutic use, or medical treatment. All information provided is for educational and scientific reference purposes only and does not constitute medical advice. Researchers are responsible for ensuring compliance with all applicable laws and regulations governing the use of research peptides in their jurisdiction, including Switzerland.